Nygaardlorentzen3280

Among the most used CAT applications in psychological and physiological rehabilitation there are the (I) co-presence during the dynamic activity (in particular the walking) and the (II) co-presence in the Area of living (mainly the home). The study focused to the CAT, introduces a conceptual model for the contemporary parameters monitoring of the two actors during the two applications (I,II) and able to provide a quantification of the utility of the CAT. It is based on to two sub-systems. The first sub-systems is a wearable mobile solution with kinematic sensors for the human and the dog monitoring in (I) during walking. The second sub-system, allowing the monitoring in (II), is based on RFID technology. Conclusions After an analysis of the literature a new model for the CAT, based on kinematic sensors and RFID technology has been proposed and will be introduced in this field. 2019 mHealth. All rights reserved.In Europe, free-ranging wildlife has been linked to the emergence of several vector-borne diseases such as rodents for Borrelia burgdorferi s.l. In particular, wild carnivorans are one of the most important sources of emerging zoonotic pathogens worldwide, although little information is available regarding the epidemiology of vector-borne parasites in these animals. Thus, the aim of this paper was to investigate the prevalence of Babesia spp., Anaplasma spp., Ehrlichia spp., Hepatozoon spp. and Leishmania infantum in alpine wild canids and mustelids from Italy. For this study, spleen samples of 157 foxes (Vulpes vulpes), 45 badgers (Meles meles), and 33 wolves (Canis lupus) collected between 2009 and 2017 in Northwest Italy were examined by using conventional PCR. Logistic regression was used to identify possible risk factors for pathogen infections. DNA of any of the tested pathogens was found in more than 90% of the analyzed animals. In particular, Babesia spp. showed significantly higher prevalence in foxes (89.7%) and badgers (89.6%) than in wolves, while the latter were considerably more infected with Hepatozoon canis (75.8%) than foxes (5.1%). None of the badger tested positive for Hepatozoon spp., although they showed high prevalence of Leishmania infantum (53.3%). Sequencing results revealed the presence, among others, of Babesia vulpes, Babesia sp. isolate badger type A and B, and Anaplasma phagocytophilum. this website Moreover, previously unreported pathogen/host associations were observed, such as Babesia capreoli in wolves and badgers. The prevalence of vector-borne pathogens observed in the present study is one of the highest reported so far, suggesting the importance of free-ranging carnivorans in the epidemiology and maintenance of the sylvatic cycle of the pathogens. Moreover, several of these pathogens are of particular importance regarding human (A. phagocytophilum, L. infantum) and pet health (L. infantum, B. vulpes). Copyright © 2020 Battisti, Zanet, Khalili, Trisciuoglio, Hertel and Ferroglio.This study was designed to determine if supplementation of a combination live yeast and yeast cell wall product in feed could mitigate the negative impacts associated with heat stress (HS). Crossbred, phenotypically similar beef heifers (n = 32; BW = 385 ± 43 kg) were fed a standard finishing ration without (CON) or with a combination of a live yeast (1.5 g/hd/d) and yeast cell wall product (2.5 g/hd/d; YEAST; Phileo Lesaffre Animal Care, Milwaukee, WI). After 50 d of supplementation, heifers were transported to an environmentally-controlled facility and placed in individual bleeding stalls after indwelling jugular catheters and vaginal temperature (VT) loggers were inserted. Heifers were kept in thermoneutral (TN) conditions for 48 h [temperature-humidity index (THI) ~67; d 1-2] then were subjected to HS for 4 d (peak THI ~80; d 3-6). From d 2-6, hourly blood samples were collected for serum isolation from 1400 to 1800 h and again from 2200 to 0200 h which represented the daily targeted peak and nadir of THIfers may mitigate some of the negative effects associated with HS in feedlot cattle as observed in decreased RR and VT and increased water intake. Copyright © 2020 Broadway, Carroll, Burdick Sanchez, Cravey and Corley.A retrospective analysis was performed to determine mortality and morbidity rates for elective and emergency cases in an equine university teaching hospital. It investigated the effect of horse-, anesthetic-, timing, and clinician experience-related variables on anesthetic complications. In total, 1,161 horses undergoing general anesthesia between January 2012 and December 2016 were included in the study. Patient information and details of the anesthetic, recovery period and immediate complications were retrieved from an archival database. Statistical analysis of qualitative and quantitative factors affecting anesthetic complications was performed using an univariable and multivariable ordinal logistic regression. Odds ratio of variables primarily affecting mortality and complications were calculated. Statistical significance was set at p less then 0.05. General anesthesia-related global mortality rate was 1.4% (95% CI [7.1-10.4]) but was only 0.96% (95% CI [0.44-1.82]) for non-colic cases. The complication rate was 17.5% (n = 204; 95% CI [15.2-20.0]) of which 46.9% [39.4-54.5] were neuromuscular, 22.6% [16.7-29.5] were respiratory, 15.8% [10.8-22.0] were systemic, 13.6% [8.9-19.5] were cardiovascular, 1.1% [0.1-4.0] were other complications. Ninety two percent of complications occurred during recovery. Major risk factors for mortality and complications included high weight, surgeon experience, increasing age, high ASA score, long duration of anesthesia, quality of induction, lateral recumbency, orthopedic surgery, and hypotension. In these models, colic surgery did not influence the rate of any complications. Copyright © 2020 Laurenza, Ansart and Portier.Cough is one of the most common complaints in human medicine. In veterinary medicine cough is equally frequent and plays a significant role in an owner's perception of their pet's quality of life. In human and veterinary medicine, therapy for chronic cough is often ineffective. The complexity of the cough pathway and species differences have made it difficult to develop an effective antitussive agent for veterinary patients. The few effective antitussive agents currently available are associated with significant adverse effects. Fortunately, several promising drugs currently being studied in human clinical trials may offer options for use of novel antitussive therapies in small animal patients. This article reviews current understanding about cough pathophysiology, diagnostic strategies used to uncover underlying etiology of cough, and examines available options for controlling cough, including novel antitussive therapies used in human medicine. Copyright © 2020 Hsieh and Beets.